Ameet Mallik's Insider Trades & SAST Disclosures
Ameet Mallik's most recent trade in Adc Therapeutics SA was a trade of 26,758 Common Shares done at an average price of $1.3 . Disclosure was reported to the exchange on May 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ameet Mallik.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.29 per share. | 06 May 2025 | 26,758 | 1,552,247 | - | 1.3 | 34,518 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 650,000 | 1,579,005 | - | 1.6 | 1,046,500 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 238,343 | 929,005 | - | 3.1 | 746,014 | Common Shares |
| Adc Therapeutics SA | Ameet Mallik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 07 May 2024 | 29,731 | 1,167,348 | - | 4.5 | 133,195 | Common Shares |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 150,000 | 227,500 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 79,500 | 79,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 57,000 | 77,500 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 31,500 | 31,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Ameet Mallik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,500 | 20,500 (0%) | 0% | 0 | Common Stock | |
| Rafael Holdings Inc - Ordi... | Ameet Mallik | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Feb 2022 | 908,497 | 0 (0%) | 6% | 0 | Class B Common Stock, par value $.01 per share | |
| Rafael Holdings Inc - Ordi... | Ameet Mallik | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 44.70 per share. | 27 May 2021 | 908,497 | 908,497 (6%) | 6% | 44.7 | 40,609,816 | Class B Common Stock, par value $.01 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges